BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22678019)

  • 21. [Treatment of non-small cell lung carcinoma].
    Souquet PJ
    Rev Prat; 2003 Apr; 53(7):747-51. PubMed ID: 12879798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolving treatment algorithms for advanced non-small-cell lung cancer: 2009 looking toward 2012.
    Gandara DR; Mack PC; Li T; Lara PN; Herbst RS
    Clin Lung Cancer; 2009 Nov; 10(6):392-4. PubMed ID: 19900855
    [No Abstract]   [Full Text] [Related]  

  • 23. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.
    Leo F; De Pas T; Catalano G; Piperno G; Curigliano G; Solli P; Veronesi G; Petrella F; Spaggiari L
    J Natl Cancer Inst; 2007 Aug; 99(15):1210; author reply 1210-1. PubMed ID: 17652281
    [No Abstract]   [Full Text] [Related]  

  • 24. [Recommendations on the therapy of bronchial carcinoma].
    Thomas M; Baumann M; Deppermann M; Freitag L; Gatzemeier U; Huber R; Passlick B; Serke M; Ukena D
    Pneumologie; 2002 Feb; 56(2):113-31. PubMed ID: 11842350
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnosis and treatment of lung cancer: summary of updated NICE guidance.
    Baldwin DR; White B; Schmidt-Hansen M; Champion AR; Melder AM;
    BMJ; 2011 Apr; 342():d2110. PubMed ID: 21525094
    [No Abstract]   [Full Text] [Related]  

  • 26. [Recommendations for surgical treatment of nonsmall cell lung cancer].
    Cordoş I; Bolca C; Paleru C
    Pneumologia; 2009; 58(2):135-40. PubMed ID: 19637769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NCCN: Non-small cell lung cancer.
    Ettinger DS; Kris MG;
    Cancer Control; 2001; 8(6 Suppl 2):22-31. PubMed ID: 11760555
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy.
    Forquer JA; Fakiris AJ; McGarry RC; Cheung MK; Watson C; Harkenrider M; Henderson MA; Lo SS
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1443-53. PubMed ID: 19828006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.
    van Meerbeeck JP; Surmont VF
    Lung Cancer; 2009 Sep; 65(3):257-67. PubMed ID: 19285751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version].
    Goeckenjan G; Sitter H; Thomas M; Branscheid D; Flentje M; Griesinger F; Niederle N; Stuschke M; Blum T; Deppermann KM; Ficker JH; Freitag L; Lübbe AS; Reinhold T; Späth-Schwalbe E; Ukena D; Wickert M; Wolf M; Andreas S; Auberger T; Baum RP; Baysal B; Beuth J; Bickeböller H; Böcking A; Bohle RM; Brüske I; Burghuber O; Dickgreber N; Diederich S; Dienemann H; Eberhardt W; Eggeling S; Fink T; Fischer B; Franke M; Friedel G; Gauler T; Gütz S; Hautmann H; Hellmann A; Hellwig D; Herth F; Heussel CP; Hilbe W; Hoffmeyer F; Horneber M; Huber RM; Hübner J; Kauczor HU; Kirchbacher K; Kirsten D; Kraus T; Lang SM; Martens U; Mohn-Staudner A; Müller KM; Müller-Nordhorn J; Nowak D; Ochmann U; Passlick B; Petersen I; Pirker R; Pokrajac B; Reck M; Riha S; Rübe C; Schmittel A; Schönfeld N; Schütte W; Serke M; Stamatis G; Steingräber M; Steins M; Stoelben E; Swoboda L; Teschler H; Tessen HW; Weber M; Werner A; Wichmann HE; Irlinger Wimmer E; Witt C; Worth H; ;
    Pneumologie; 2011 Aug; 65(8):e51-75. PubMed ID: 21830177
    [No Abstract]   [Full Text] [Related]  

  • 31. Analysis of multidisciplinary lung cancer practice.
    Conron M; Phuah S; Steinfort D; Dabscheck E; Wright G; Hart D
    Intern Med J; 2007 Jan; 37(1):18-25. PubMed ID: 17199840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New therapeutic approaches for early stage non-small cell lung cancer.
    El-Sherif A; Luketich JD; Landreneau RJ; Fernando HC
    Surg Oncol; 2005 Jul; 14(1):27-32. PubMed ID: 15777887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation and management of patients with stage IIIA (N2) non-small-cell lung cancer.
    Garland L; Robinson LA; Wagner H
    Chest Surg Clin N Am; 2001 Feb; 11(1):69-100, viii. PubMed ID: 11253602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of non-small-cell lung cancer.
    Hadeed VA; Jett JR
    Compr Ther; 1996 Oct; 22(10):641-8. PubMed ID: 8950080
    [No Abstract]   [Full Text] [Related]  

  • 35. Practice variation: the Achilles' heel in quality cancer care.
    Dilts DM
    J Clin Oncol; 2005 Sep; 23(25):5881-2. PubMed ID: 16087953
    [No Abstract]   [Full Text] [Related]  

  • 36. Postoperative chemotherapy for n2 non-small-cell lung cancer: conclusions are not black and white, but gray.
    Hanna NH; Einhorn LH
    J Clin Oncol; 2006 Dec; 24(35):5611-2; author reply 5612-3. PubMed ID: 17158549
    [No Abstract]   [Full Text] [Related]  

  • 37. Quality assessment in oncology.
    Albert JM; Das P
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):773-81. PubMed ID: 22445001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Completeness of lung cancer surgery: is mediastinal dissection common practice?
    Verhagen AF; Schoenmakers MC; Barendregt W; Smit H; van Boven WJ; Looijen M; van der Heijden EH; van Swieten HA
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):834-8. PubMed ID: 22290900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer.
    Johnson DH; Rusch VW; Turrisi AT
    J Natl Cancer Inst; 2007 Mar; 99(6):415-8. PubMed ID: 17374824
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapy for non-small-cell lung carcinoma (NSCLC) in stage IV].
    Deppermann KM; Huber RM; Laack E; Reck M; Serke M; von Pawel J
    Onkologie; 2006 Sep; 29 Suppl 2():15-9. PubMed ID: 16974123
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.